Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care Unit.

Adrian WongChristine RehrDiane L SegerMary G AmatoPatrick E BeelerSarah P SlightAdam WrightDavid W Bates

Published in: Drug safety (2020)

Overriding high dose-range CDS alerts was found to be common and often appropriate, suggesting that more intelligent dose checking is needed. Some alerts were clearly inappropriately presented to the provider. Inappropriate overrides were associated with an increased risk of ADEs, compared to appropriately overridden alerts.

Keyphrases

high dose
clinical decision support
low dose
stem cell transplantation
electronic health record
primary care
quantum dots